Subjects With Resectable Liver Cancer
1 clinical trials · Condition
◉ Watch Subjects With Resectable Liver Cancer
| Record | Firm | Date |
|---|---|---|
| Phase II Study of Neoadjuvant Immune Checkpoint Inhibitor in Patients With Resectable Gastrointestinal Cancers (NCT04196465) | Asan Medical Center | 2019-09-09 |
Track Subjects With Resectable Liver Cancer automatically
Every clearance here is in the API, with alerts when new ones post.